Literature DB >> 11891833

A novel tau mutation, S320F, causes a tauopathy with inclusions similar to those in Pick's disease.

Sonia M Rosso1, Esther van Herpen, Wout Deelen, Wouter Kamphorst, Lies-Anne Severijnen, Rob Willemsen, Rivka Ravid, Martinus F Niermeijer, Dennis Dooijes, Michael J Smith, Michel Goedert, Peter Heutink, John C van Swieten.   

Abstract

Mutations in the tau gene cause familial frontotemporal dementia and parkinsonism linked to chromosome 17. In this article, we describe a novel missense mutation, S320F, in the tau gene in a family with presenile dementia. To our knowledge, it is the first mutation to be described in exon 11 of tau. The proband died at age 53 years, after a disease duration of 15 years, and autopsy revealed a neuropathological picture similar to Pick's disease. Recombinant tau protein with the S320F mutation showed a greatly reduced ability to promote microtubule assembly.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11891833     DOI: 10.1002/ana.10140

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  22 in total

1.  Mutations in tau gene exon 10 associated with FTDP-17 alter the activity of an exonic splicing enhancer to interact with Tra2 beta.

Authors:  Zhihong Jiang; Hao Tang; Necat Havlioglu; Xiaochun Zhang; Stefan Stamm; Riqiang Yan; Jane Y Wu
Journal:  J Biol Chem       Date:  2003-03-20       Impact factor: 5.157

2.  A Novel Tau Mutation in Exon 12, p.Q336H, Causes Hereditary Pick Disease.

Authors:  Pawel Tacik; Michael DeTure; Kelly M Hinkle; Wen-Lang Lin; Monica Sanchez-Contreras; Yari Carlomagno; Otto Pedraza; Rosa Rademakers; Owen A Ross; Zbigniew K Wszolek; Dennis W Dickson
Journal:  J Neuropathol Exp Neurol       Date:  2015-11       Impact factor: 3.685

3.  A novel tau mutation, p.K317N, causes globular glial tauopathy.

Authors:  Pawel Tacik; Michael DeTure; Wen-Lang Lin; Monica Sanchez Contreras; Aleksandra Wojtas; Kelly M Hinkle; Shinsuke Fujioka; Matthew C Baker; Ronald L Walton; Yari Carlomagno; Patricia H Brown; Audrey J Strongosky; Naomi Kouri; Melissa E Murray; Leonard Petrucelli; Keith A Josephs; Rosa Rademakers; Owen A Ross; Zbigniew K Wszolek; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2015-04-22       Impact factor: 17.088

4.  Isoform-selective Genetic Inhibition of Constitutive Cytosolic Hsp70 Activity Promotes Client Tau Degradation Using an Altered Co-chaperone Complement.

Authors:  Sarah N Fontaine; Jennifer N Rauch; Bryce A Nordhues; Victoria A Assimon; Andrew R Stothert; Umesh K Jinwal; Jonathan J Sabbagh; Lyra Chang; Stanley M Stevens; Erik R P Zuiderweg; Jason E Gestwicki; Chad A Dickey
Journal:  J Biol Chem       Date:  2015-04-11       Impact factor: 5.157

5.  Single mutations in tau modulate the populations of fibril conformers through seed selection.

Authors:  Virginia Meyer; Paul D Dinkel; Yin Luo; Xiang Yu; Guanghong Wei; Jie Zheng; Gareth R Eaton; Buyong Ma; Ruth Nussinov; Sandra S Eaton; Martin Margittai
Journal:  Angew Chem Int Ed Engl       Date:  2014-01-22       Impact factor: 15.336

6.  A Conserved Cytoskeletal Signaling Cascade Mediates Neurotoxicity of FTDP-17 Tau Mutations In Vivo.

Authors:  Farah H Bardai; Liqun Wang; Yamini Mutreja; Mythili Yenjerla; T Chris Gamblin; Mel B Feany
Journal:  J Neurosci       Date:  2017-11-14       Impact factor: 6.167

7.  Phosphorylation of serine 305 in tau inhibits aggregation.

Authors:  Kevin H Strang; Zachary A Sorrentino; Cara J Riffe; Kimberly-Marie M Gorion; Niran Vijayaraghavan; Todd E Golde; Benoit I Giasson
Journal:  Neurosci Lett       Date:  2018-11-10       Impact factor: 3.046

Review 8.  Tau alternative splicing and frontotemporal dementia.

Authors:  Amar Kar; David Kuo; Rongqiao He; Jiawei Zhou; Jane Y Wu
Journal:  Alzheimer Dis Assoc Disord       Date:  2005 Oct-Dec       Impact factor: 2.703

Review 9.  The cytoskeleton in neurodegenerative diseases.

Authors:  Nigel J Cairns; Virginia M-Y Lee; John Q Trojanowski
Journal:  J Pathol       Date:  2004-11       Impact factor: 7.996

10.  Combining P301L and S320F tau variants produces a novel accelerated model of tauopathy.

Authors:  Emily J Koller; Elsa Gonzalez De La Cruz; Timothy Machula; Kristen R Ibanez; Wen-Lang Lin; Tosha Williams; Cara J Riffe; Daniel Ryu; Kevin H Strang; Xuefei Liu; Christopher Janus; Todd E Golde; Dennis Dickson; Benoit I Giasson; Paramita Chakrabarty
Journal:  Hum Mol Genet       Date:  2019-10-01       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.